ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.60145
-0.12%
Brent Oil
81.995
-0.55%
Bitcoin
70,004.52
-0.18%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cogent Biosciences Inc (COGT)

  7. Cogent Biosciences Inc (COGT) Noticias

COGT

Cogent Biosciences (COGT)

Cogent Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:COGT
FechaHoraFuenteTítuloSímboloCompañía
07/05/202407:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:COGTCogent Biosciences Inc
07/05/202407:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COGTCogent Biosciences Inc
07/05/202407:00GlobeNewswire Inc.Cogent Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ:COGTCogent Biosciences Inc
09/04/202408:00GlobeNewswire Inc.Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 InhibitorNASDAQ:COGTCogent Biosciences Inc
26/02/202415:34Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:COGTCogent Biosciences Inc
26/02/202408:13Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:COGTCogent Biosciences Inc
26/02/202407:00GlobeNewswire Inc.Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:COGTCogent Biosciences Inc
22/02/202413:30GlobeNewswire Inc.Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic MastocytosisNASDAQ:COGTCogent Biosciences Inc
16/02/202417:55Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:COGTCogent Biosciences Inc
16/02/202417:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COGTCogent Biosciences Inc
14/02/202415:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:COGTCogent Biosciences Inc
14/02/202411:51Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:COGTCogent Biosciences Inc
14/02/202406:00GlobeNewswire Inc.Cogent Biosciences Announces Oversubscribed $225 Million Private PlacementNASDAQ:COGTCogent Biosciences Inc
05/02/202408:00GlobeNewswire Inc.Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual MeetingNASDAQ:COGTCogent Biosciences Inc
09/01/202407:00GlobeNewswire Inc.Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted TherapeuticsNASDAQ:COGTCogent Biosciences Inc
02/01/202407:00GlobeNewswire Inc.Cogent Biosciences Announces Presentation at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:COGTCogent Biosciences Inc
11/12/202306:55GlobeNewswire Inc.Cogent Biosciences Announces Positive Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)NASDAQ:COGTCogent Biosciences Inc
09/12/202312:30GlobeNewswire Inc.Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)NASDAQ:COGTCogent Biosciences Inc
07/12/202308:00GlobeNewswire Inc.Cogent Biosciences Presents New Preclinical Data Highlighting Potential Best-in-Class Potency and Selectivity of ErbB2 and PI3Kα inhibitor programs at the San Antonio Breast Cancer SymposiumNASDAQ:COGTCogent Biosciences Inc
04/12/202307:00GlobeNewswire Inc.Cogent Biosciences to Host Investor Webcast on December 11, 2023 at 8:00 AM ET to Review Clinical Data Being Presented at American Society of Hematology (ASH) Annual MeetingNASDAQ:COGTCogent Biosciences Inc
29/11/202307:00GlobeNewswire Inc.Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer SymposiumNASDAQ:COGTCogent Biosciences Inc
02/11/202308:00GlobeNewswire Inc.Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2023 Financial ResultsNASDAQ:COGTCogent Biosciences Inc
14/10/202311:30GlobeNewswire Inc.Cogent Biosciences Presents Preclinical Data Highlighting Precision Oncology Pipeline at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:COGTCogent Biosciences Inc
08/08/202307:00GlobeNewswire Inc.Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2023 Financial ResultsNASDAQ:COGTCogent Biosciences Inc
13/06/202315:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:COGTCogent Biosciences Inc
13/06/202315:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:COGTCogent Biosciences Inc
09/06/202315:01GlobeNewswire Inc.Cogent Biosciences Announces Closing of Upsized Public Offering of Common StockNASDAQ:COGTCogent Biosciences Inc
08/06/202315:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:COGTCogent Biosciences Inc
08/06/202315:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:COGTCogent Biosciences Inc
07/06/202308:00GlobeNewswire Inc.Cogent Biosciences Announces Participation in the Jefferies Healthcare ConferenceNASDAQ:COGTCogent Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:COGT

Su Consulta Reciente

COIN
SOLUSD
Solana
NYSE
CVX
Chevron
USOTC
BNPQY
BNP Paribas (QX)
FX
EURUSD
Euro vs US Dollar
COIN
BTCUSD
Bitcoin
NYSE
AXP
American Express
AMEX
XLV
Health Care Select Sector
USOTC
BASFY
BASF (QX)
COIN
ETHUSD
Ethereum
CCOM
US30
US 30
PM
XAUUSD
Gold vs US Dollar
NASDAQ
AMZN
Amazon.com
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados